Introduction Dementia has been associated with COVID‐19 prevalence, but whether this reflects higher infection, older age of patients, or disease severity remains unclear. Methods …
Y Hu, H Yang, C Hou, W Chen, H Zhang, Z Ying, Y Hu… - BMC neurology, 2022 - Springer
Background An increased susceptibility to COVID-19 has been suggested for individuals with neurodegenerative diseases, but data are scarce from longitudinal studies. Methods In …
Previous studies have identified dementia as a risk factor for death from coronavirus disease 2019 (COVID-19). However, it is unclear whether Alzheimer's disease (AD) is an …
BackgroundPeople with neurodegenerative disease and mild cognitive impairment (MCI) may have an elevated risk of acquiring severe acute respiratory syndrome coronavirus 2 …
L Wang, PB Davis, ND Volkow… - Journal of …, 2022 - content.iospress.com
An infectious etiology of Alzheimer's disease has been postulated for decades. It remains unknown whether SARS-CoV-2 viral infection is associated with increased risk for …
Since patients with Alzheimer's disease are at higher risk for hospitalization and death in the setting of COVID-19, additional precautions and protective measures should be put in place …
K Numbers, H Brodaty - Nature Reviews Neurology, 2021 - nature.com
The COVID-19 pandemic has posed unique risks to people with Alzheimer disease and dementia. Research from 2020 has shown that these people have a relatively high risk of …
COVID‐19 causes lasting neurological symptoms in some survivors. Like other infections, COVID‐19 may increase risk of cognitive impairment. This perspective highlights four …
The current coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2, is affecting every aspect of global society …